États-Unis · Agences & temps réel · Bloomberg

All-or-Nothing Biotech Bets Dented by Rising Treasury Yields

Publié par Bloomberg · États-Unis il y a 3 h

Investors are beginning to turn cautious on biotechnology stocks as a rapid rise in Treasury yields dents the appeal for shares of companies that are often viewed as risky…

Lire l'article complet sur Bloomberg Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.bloomberg.com)

All-or-Nothing Biotech Bets Dented by Rising Treasury Yields

À lire aussi

ELEGOO Brings Professional-Grade 3D Scanning to a Wider Range of Creators with the Upcoming M1 Ultra

Lyric Releases Framework for Measuring Healthcare Decision Intelligence Maturity in Payment Accuracy

Coastal construction projects threaten the mangrove forest that protects Vietnam’s biggest city

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows

All-or-Nothing Biotech Bets Dented by Rising Treasury Yields

Partager

À lire aussi

ELEGOO Brings Professional-Grade 3D Scanning to a Wider Range of Creators with the Upcoming M1 Ultra

Lyric Releases Framework for Measuring Healthcare Decision Intelligence Maturity in Payment Accuracy

Coastal construction projects threaten the mangrove forest that protects Vietnam’s biggest city

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows